Modulation of oxidative cell damage by reconstituted mixtures of phenolic apple juice extracts in human colon cell lines.
Diets rich in fruits and vegetables are associated with a lower risk of tumour induction in the intestine and other sites. Apple juice with high amounts of antioxidative phenolics might protect the intestine against reactive oxygen species-mediated cell damage. We investigated to which extent the preventive effectiveness of polyphenolic juice extracts is governed by the amounts of five major constituents (rutin, phloridzin, chlorogenic acid, caffeic acid and epicatechin). In human colon cell lines (Caco-2, HT29), reconstituted mixtures of these phenolics were investigated in comparison to the original juice extracts, originating from cider and table apples. Parameters studied were (oxidative) DNA damage (Comet assay), cellular redox status (dichlorofluorescein assay) and Trolox equivalent antioxidant capacity (TEAC). The TEAC of the reconstituted mixtures was higher compared to the respective original extracts (4.7-7.3 mM vs. 3.6-4.2 mM Trolox). After 24 h cell incubation, menadione-induced (oxidative) DNA damage was more effectively reduced by the reconstituted mixtures (1-100 microg/mL, 24 h), as compared to the original extracts. In contrast, the cellular ROS level was reduced to a rather similar extent by original extracts and reconstituted mixtures. The results lead to the conclusion that the selected constituents in their authentic proportions substantially account for the antioxidative effectiveness of phenolic apple juice extracts.
Division of Food Chemistry & Environmental Toxicology, Department of Chemistry, University of Kaiserslautern, Germany.
Sandra
S
Schaefer
Matthias
M
Baum
Gerhard
G
Eisenbrand
Christine
C
Janzowski
D000975:Antioxidants / Q000494:pharmacology*; D001628:Beverages / Q000032:analysis; D018938:Caco-2 Cells; D002109:Caffeic Acids / Q000494:pharmacology; D002392:Catechin / Q000494:pharmacology; D002460:Cell Line; D002726:Chlorogenic Acid / Q000494:pharmacology; D002839:Chromans; D003106:Colon / Q000187:drug effects*; D003110:Colonic Neoplasms / Q000209:etiology / Q000517:prevention & control; D004249:DNA Damage / Q000187:drug effects; D005419:Flavonoids / Q000494:pharmacology*; D005638:Fruit / Q000737:chemistry*; D019073:HT29 Cells; D006801:Humans; D027845:Malus / Q000737:chemistry*; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects*; D010636:Phenols / Q000494:pharmacology*; D010695:Phlorhizin / Q000494:pharmacology; D059808:Polyphenols; D012431:Rutin / Q000494:pharmacology
D000975:Antioxidants; D002109:Caffeic Acids; D002839:Chromans; D005419:Flavonoids; D010636:Phenols; D059808:Polyphenols; D002726:Chlorogenic Acid; D012431:Rutin; D002392:Catechin; D010695:Phlorhizin; C010643:6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid; C040048:caffeic acid